Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ketoconazole × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 22 CNS 6 Tumor-Agnostic 5 Lymphoid 5 Other solid neoplasm 4 Other hematologic neoplasm 3 Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 610 Paclitaxel 573 Cyclophosphamide 545 Docetaxel 484 Capecitabine 425 Letrozole 362 Fulvestrant 328 Carboplatin 324 Doxorubicin 285 Tamoxifen 259 Anastrozole 228 pembrolizumab 225 Radiotherapy 213 exemestane 212 Epirubicin 204 Bevacizumab 188 pertuzumab 187 palbociclib 175 Gemcitabine 175 Vinorelbine 169 Lapatinib 159 Magnetic Resonance Spectroscopy 147 130-nm albumin-bound paclitaxel 142 eribulin 132 Surveys and Questionnaires 130 Albumin-Bound Paclitaxel 129 Exercise 124 Fluorouracil 113 Drug Therapy 110 Blood Specimen Collection 107

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00212095 2012-11-01

Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer

National University Hospital, Singapore

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡